Advertisement

Topics

Collegium's opioid pain drug label update approved by FDA

04:55 EST 8 Nov 2017 | SmartBrief

A supplemental new drug application was approved by the FDA for Collegium Pharmaceuticals' Xtampza ER, or oxycodone extended- -More

Original Article: Collegium's opioid pain drug label update approved by FDA

NEXT ARTICLE

More From BioPortfolio on "Collegium's opioid pain drug label update approved by FDA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...